Teleflex Incorporated
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $209.82
- Today's High:
- $211.87
- Open Price:
- $211.19
- 52W Low:
- $181.58
- 52W High:
- $275.6405
- Prev. Close:
- $211.79
- Volume:
- 222585
Company Statistics
- Market Cap.:
- $9.95 billion
- Book Value:
- 89.7
- Revenue TTM:
- $2.90 billion
- Operating Margin TTM:
- 18.93%
- Gross Profit TTM:
- $1.55 billion
- Profit Margin:
- 12.71%
- Return on Assets TTM:
- 5.04%
- Return on Equity TTM:
- 9.14%
Company Profile
Teleflex Incorporated had its IPO on 1988-02-18 under the ticker symbol TFX.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Teleflex Incorporated has a staff strength of 15,500 employees.
Stock update
Shares of Teleflex Incorporated opened at $211.19 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $209.82 - $211.87, and closed at $210.51.
This is a -0.6% slip from the previous day's closing price.
A total volume of 222,585 shares were traded at the close of the day’s session.
In the last one week, shares of Teleflex Incorporated have slipped by -1.42%.
Teleflex Incorporated's Key Ratios
Teleflex Incorporated has a market cap of $9.95 billion, indicating a price to book ratio of 2.9785 and a price to sales ratio of 4.1968.
In the last 12-months Teleflex Incorporated’s revenue was $2.90 billion with a gross profit of $1.55 billion and an EBITDA of $785.17 million. The EBITDA ratio measures Teleflex Incorporated's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Teleflex Incorporated’s operating margin was 18.93% while its return on assets stood at 5.04% with a return of equity of 9.14%.
In Q2, Teleflex Incorporated’s quarterly earnings growth was a positive 5.3% while revenue growth was a positive 5.5%.
Teleflex Incorporated’s PE and PEG Ratio
- Forward PE
- 22.2717
- Trailing PE
- 27.1874
- PEG
- 3.1295
Its diluted EPS in the last 12-months stands at $7.79 per share while it has a forward price to earnings multiple of 22.2717 and a PEG multiple of 3.1295. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Teleflex Incorporated’s profitability.
Teleflex Incorporated stock is trading at a EV to sales ratio of 8.8327 and a EV to EBITDA ratio of 34.3984. Its price to sales ratio in the trailing 12-months stood at 4.1968.
Teleflex Incorporated stock pays annual dividends of $1.36 per share, indicating a yield of 0.64% and a payout ratio of 10.23%.
Balance sheet and cash flow metrics
- Total Assets
- $6.90 billion
- Total Liabilities
- $555.45 million
- Operating Cash Flow
- $-7329000.00
- Capital Expenditure
- $17.54 million
- Dividend Payout Ratio
- 10.23%
Teleflex Incorporated ended 2024 with $6.90 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $6.90 billion while shareholder equity stood at $4.22 billion.
Teleflex Incorporated ended 2024 with $385.11 million in deferred long-term liabilities, $555.45 million in other current liabilities, 47998000.00 in common stock, $3.97 billion in retained earnings and $2.55 billion in goodwill. Its cash balance stood at $250.82 million and cash and short-term investments were $250.82 million. The company’s total short-term debt was $87,500,000 while long-term debt stood at $1.47 billion.
Teleflex Incorporated’s total current assets stands at $1.45 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $429.31 million compared to accounts payable of $142.08 million and inventory worth $631.56 million.
In 2024, Teleflex Incorporated's operating cash flow was $-7329000.00 while its capital expenditure stood at $17.54 million.
Comparatively, Teleflex Incorporated paid $0.10 in dividends in 2024.
Other key metrics
- Current Trading Price
- $210.51
- 52-Week High
- $275.6405
- 52-Week Low
- $181.58
- Analyst Target Price
- $268.15
Teleflex Incorporated stock is currently trading at $210.51 per share. It touched a 52-week high of $275.6405 and a 52-week low of $275.6405. Analysts tracking the stock have a 12-month average target price of $268.15.
Its 50-day moving average was $232.13 and 200-day moving average was $241.77 The short ratio stood at 5.69 indicating a short percent outstanding of 0%.
Around 22.6% of the company’s stock are held by insiders while 10002% are held by institutions.
Frequently Asked Questions About Teleflex Incorporated
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.